FLATRO

This brand name is authorized in Nigeria.

Active ingredients

The drug FLATRO contains one active pharmaceutical ingredient (API):

1	Methronidazole UNII 140QMO216E - METRONIDAZOLE
	Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.
	Read more about Methronidazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1807	Solution for infusion	Flatro Infusion INJ_SOL 500 mg/100 mL 1 x 100 mL (in LDPE bottles)	An almost colorless to pale yellow solution for infusion	26/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XD01	Metronidazole	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives
Discover more medicines within J01XD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1807